A randomized placebo-controlled trial of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis from East Asia and other countries

被引：0
|
作者：
Takahiko Saida
Takashi Yamamura
Takayuki Kondo
Jang Yun
Minhua Yang
Jie Li
Lalitha Mahadavan
Bing Zhu
Sarah I. Sheikh
机构：
[1] Kyoto Min-iren Central Hospital,Kansai Multiple Sclerosis Centre
[2] National Center Hospital,NCNP
[3] Kansai Medical University Medical Center,undefined
[4] Biogen,undefined
[5] Sanofi,undefined
[6] Faculty of Pharmaceutical Medicine,undefined
来源：
BMC Neurology | / 19卷
关键词：
Delayed-release dimethyl fumarate; East Asia; Japan; Magnetic resonance imaging; Multiple sclerosis; Randomized clinical trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Overall safety and efficacy through 10 years of treatment with delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Bar-Or, A.
    Fox, R. J.
    Chen, C.
    Miller, C.
    Branco, F.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 772 - 773
  • [22] Clinical efficacy of delayed-release dimethyl fumarate in Hispanic patients with relapsing-remitting multiple sclerosis: integrated analysis of define and confirm
    Hernandez, L.
    Fox, R. J.
    Gold, R.
    Phillips, J. T.
    Okwuokeny, M.
    Zhang, A.
    Rana, J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E306 - E306
  • [23] A Retrospective Analysis of Real-World Discontinuation Rates with Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis
    Allan, Michelle
    Grant, Lindsay
    NEUROLOGY AND THERAPY, 2020, 9 (01) : 85 - 92
  • [24] CONCERTO: A randomized, placebo-controlled trial of oral laquinimod in relapsing-remitting multiple sclerosis
    Comi, Giancarlo
    Dadon, Yuval
    Sasson, Nissim
    Steinerman, Joshua R.
    Knappertz, Volker
    Vollmer, Timothy L.
    Boyko, Alexey
    Vermersch, Patrick
    Ziemssen, Tjalf
    Montalban, Xavier
    Lublin, Fred D.
    Rocca, Maria A.
    Volkinshtein, Rita
    Rubinchick, Svetlana
    Halevy, Nitsan
    Filippi, Massimo
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (04) : 608 - 619
  • [25] Cost-effectiveness analysis of delayed-release dimethyl-fumarate in the treatment of relapsing-remitting multiple sclerosis in Italy
    Furneri, Gianluca
    Santoni, Laura
    Marchesi, Chiara
    Iannazzo, Sergio
    Cortesi, Paolo Angelo
    Piacentini, Patrizio
    Caputi, Achille Patrizio
    Mantovani, Lorenzo Giovanni
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2016, 17 (02) : 67 - 80
  • [26] COST-EFFECTIVENESS ANALYSIS OF DELAYED-RELEASE DIMETHYL-FUMARATE IN THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS IN ITALY
    Fumeri, G.
    Santoni, L.
    Marchesi, C.
    Iannazzo, S.
    Cortesi, R.
    Piacentini, P.
    Caputi, A.
    Mantovani, L. G.
    VALUE IN HEALTH, 2015, 18 (07) : A697 - A697
  • [27] Delayed-release Dimethyl Fumarate Demonstrates Sustained Efficacy over Nine Years in Newly Diagnosed Patients with Relapsing-Remitting Multiple Sclerosis
    Gold, Ralf
    Giovannoni, Gavin
    Phillips, J. Theodore
    Bar-Or, Amit
    Fox, Robert J.
    Chen, Chongshu
    Miller, Catherine
    NEUROLOGY, 2019, 92 (15)
  • [28] Delayed-release dimethyl fumarate demonstrates sustained efficacy over nine years in newly diagnosed patients with relapsing-remitting multiple sclerosis
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Bar-Or, A.
    Fox, R. J.
    Chen, C.
    Miller, C.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 498 - 499
  • [29] MRI Outcomes at Seven Years in Relapsing-Remitting Multiple Sclerosis Patients Treated With Delayed-release Dimethyl Fumarate in DEFINE, CONFIRM, and ENDORSE
    Arnold, Douglas L.
    Fox, Robert J.
    Gold, Ralf
    Havrdova, Eva
    Kappos, Ludwig
    Yousry, Tarek
    MacManus, David
    Yang, Lili
    Riester, Katherine
    Taylor, Catherine
    Fay, Monica
    NEUROLOGY, 2017, 88
  • [30] CONCERTO: a placebo-controlled trial of oral laquinimod in patients with relapsing-remitting multiple sclerosis
    Comi, G.
    Vollmer, T. L.
    Boyko, A.
    Vermersch, P.
    Ziemssen, T.
    Montalban, X.
    Lublin, F. D.
    Sasson, N.
    Dadon, Y.
    Steinerman, J. R.
    Knappertz, V.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 74 - 75
12345